| 查看: 1018 | 回复: 5 | ||
| 【奖励】 本帖被评价5次，作者lwjxz增加金币 4 个 | ||
[资源]
2011.07.21～22生物利用度/生物等效性（BA/BE）国际高级研习班（苏州）资料--1 PDF版
|
||
|
下载：http://ishare.iask.sina.com.cn/f/17812763.html 培训班授课专家 1. Gordon Amidon Ph.D., College of Pharmacy, University of Michigan, USA Dr. Gordon L. Amidon received his B.S. degree from the State University of New York, Buffalo (1967), an M.A. degree in Mathematics (1970) and Ph.D. in Pharmaceutical Chemistry (1971) from The University of Michigan. From 1971 to 1981 Dr. Amidon was a member of the faculty at the University of Wisconsin. Dr. Amidon was appointed Professor of Pharmaceutics at The University of Michigan in 1983 and was named the Charles R. Walgreen, Jr., Professor of Pharmacy in 1994. Dr. Amidon is internationally known for his research in the field of drug absorption, transport phenomena, solubility and dissolution, and prodrugs. He has published extensively in journals, with over 300 published papers and 370 abstracts, 18 US patents, contributed chapters to over 30 books and monographs and is co-editor of eight books. Professor Amidon has mentored over 80 doctoral and postdoctoral students with more than 20 selecting academic careers. He has received numerous awards including; best paper awards in the Journal of Pharmaceutical Sciences (1975, 1981, 1984) and Pharmaceutical Research (2004); the Scheele Award of the Swedish Academy of Pharmaceutical Sciences for outstanding contributions to the field of oral drug delivery and biopharmaceutics (1996). He received an honorary Doctor of Pharmacy degree from the University of Uppsala, Sweden (2001); the Founders Award of the Controlled Release Society (2003); the Volwiler Award of the American Association of Colleges of Pharmacy (2004); the AAPS Distinguished Pharmaceutical Scientist Award (2005); the FIP Distinguished Pharmaceutical Scientist Award (2006), the Gerhard Levy Distinguished Lectureship (2006), the Alexander von Humboldt Research Award (2009), and the Japan Society for the Promotion of Science (JSPS) Award (2011). He has organized and participated in many international symposia and workshops. Dr. Amidon developed a Biopharmaceutics Classification System (BCS), with the FDA, impacting bioequivalence standards worldwide. He is a Fellow of the AAPS, APhA/APS, and the AAAS. He is a member of the Controlled Release Society, serving as president in 1994, AACP, ACS and AAPS, serving as president in 1998. Professor Amidon is the editor of the American Chemical Society Journal, Molecular Pharmaceutics. |
回复此楼» 猜你喜欢
海勃原辅料助力银屑病一线外用制剂开发
已经有0人回复
-
请教执业药师报考的一些问题
已经有4人回复
-
药物学论文润色/翻译怎么收费?
已经有195人回复
-
二乙烯基砜的合成路径
已经有4人回复
-
求一株[b]敲除MTAP(human)的HCT-116(人结肠癌细胞)/b]细胞
已经有0人回复
-
求助！求美国食品化学药典内容：FCC13【低聚果糖专论】
已经有0人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
消耗微量API，便可预测早期研发阶段的HME工艺可行性
已经有0人回复
-
反应液中苯酐除去
已经有1人回复
-
看过往病历，有疑惑请教
已经有0人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 芬兰奥卢大学生物中心招聘公派联合培养,公派读博，访问学者和相关学生
已经有14人回复
6楼2015-03-29 16:37:32
简单回复
2011-08-06 17:59
回复
五星好评 
lrwy3楼
2011-08-06 21:28
回复
五星好评 
News4楼
2011-08-06 21:46
回复
五星好评 
小樱桃5楼
2012-08-06 11:12
回复
五星好评 顶一下！！
